Brief: Bioretec Enters Into 5-Year Exclusive Distribution Agreement
May 12 (Reuters) - Bioretec Oy BRETEC.HE :
* ENTERS INTO A DISTRIBUTION AGREEMENT WITH AMI MEDICAL
TECHNOLOGIES FOR BIORESORBABLE ACTIVA PRODUCTS IN ISRAEL
* UNDER 5-YEAR EXCLUSIVE AGREEMENT, AMI MEDICAL TECHNOLOGIES
WILL
DISTRIBUTE, PROMOTE AND SELL BIORETEC'S BIORESORBABLE ACTIVA
IMPLANTS IN ISRAEL
Source text for Eikon: ID:nWkrbwrJT
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million